AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimihop M 2mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Anax Lifescience

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimihop M 2mg/500mg Tablet PR

Diabetic patients (adults) utilize the anti-diabetic medication, Glimihop M 2mg/500mg Tablet PR, a dual-medicine formulation, to manage type 2 diabetes mellitus. This medication effectively regulates blood glucose. Administer Glimihop M with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Common side effects include hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures (fast-acting glucose, like sugary foods or juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment. Pregnant or lactating individuals should seek medical consultation prior to use. Regular blood glucose monitoring is essential, and your physician may recommend blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimihop M 2mg/500mg Tablet PR

There is no text provided to rephrase.

Uses of Glimihop M 2mg/500mg Tablet PR

Managing Type 2 diabetes

Major Benefits of Glimihop M 2mg/500mg Tablet PR:

Follow your physician's guidance or consult the product label for administration instructions. Take Glimihop M 2mg/500mg Tablet PR with a meal.

Common Side effects of Glimihop M 2mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimihop M 2mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Consume Glimihop M 2mg/500mg Tablet PR with a meal.

How Glimihop M 2mg/500mg Tablet PR works:

Glimihop M 2mg/500mg tablets are a dual-action antidiabetic formulation containing glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, retarding intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimihop M 2mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimihop M 2mg/500mg Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glimihop M 2mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Caution is advised when prescribing Glimihop M 2mg/500mg Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not use Glimihop M 2mg/500mg Tablet PR. A physician's consultation is recommended. Regular monitoring of kidney function is prudent during treatment with this medication.

LiverLiverCAUTION

Exercise caution when prescribing Glimihop M 2mg/500mg Tablet PR to individuals with hepatic impairment. Dosage modifications may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver disease, initiate treatment with a reduced Glimihop M 2mg/500mg Tablet PR dose; however, its administration is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimihop M 2mg/500mg Tablet PR :

Should you forget to take a Glimihop M 2mg/500mg Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimihop M 2mg/500mg Tablet PR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimihop M 2mg/500mg Tablet PR

Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Ensure its inaccessibility to children, pets, and others.
Glimihop M 2mg/500mg Tablet PR use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is particularly risky for individuals with kidney impairment, the elderly, or those who consume significant alcohol. Symptoms may encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Glimihop M 2mg/500mg Tablet PR and seek immediate medical attention.
Glimihop M 2mg/500mg tablets contain glimepiride and metformin, two medications used together to manage type 2 diabetes mellitus in adults. This dual therapy enhances blood sugar control when combined with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose production and augmenting insulin sensitivity. This formulation is unsuitable for treating type 1 diabetes mellitus.
Glimihop M 2mg/500mg tablets may cause common adverse reactions including low blood glucose, taste disturbances, nausea, abdominal discomfort, loose stools, and cephalalgia. Rare but potentially severe side effects such as lactic acidosis may occur. Prolonged administration may result in vitamin B12 deficiency.
Prolonged use of Glimihop M 2mg/500mg Tablet PR can indeed lead to Vitamin B12 deficiency. This medication hinders Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures, proposed by some studies, include supplemental Vitamin B12 at least annually.
Indeed, Glimihop M 2mg/500mg Tablet PR can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Always carry readily available glucose sources such as glucose tablets, honey, or fruit juice.
Combining Glimihop M 2mg/500mg tablets with alcohol is unsafe. This combination can reduce blood sugar, potentially causing hypoglycemia, and raise the risk of lactic acidosis.
Glimihop M 2mg/500mg Tabl...
72
MRP 88
18% off